Huller Kelly 4

What Happened

• Huller Kelly, EVP, General Counsel and Corporate Secretary of Globus Medical (GMED), was granted 40,000 derivative securities (stock options/award) on January 21, 2026. The Form 4 reports an acquisition at $0.00, indicating these are an equity award rather than a cash purchase or sale. The filing does not state an exercise price or aggregate dollar value for the grant.

Key Details

• Transaction date: January 21, 2026; Filing date (Accession): January 23, 2026 (filed within the typical two-business-day window for Form 4).
• Reported transaction type: A (award/grant of derivative securities); amount: 40,000 shares (options) at $0.00.
• Shares owned after transaction: Not specified in the supplied summary of the filing.
• Footnote: These options vest over four years — 1/4 of the options vest on January 1, 2027, then 1/48 of the total options vest each month thereafter (per footnote F1).
• No 10b5-1 plan, tax-withholding, cashless exercise, or late-filing flag was reported in the provided details.

Context

• This filing documents an equity compensation grant (not an exercise or open-market buy), which is common for executive compensation and does not by itself signal a personal purchase or sale of stock. The award will convert into vested option rights over time per the stated vesting schedule; any future exercise or sale would generate separate Form 4 disclosures.